Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma

Fig. 5

Comparison of ANK2 expression in healthy tissue versus tumor tissue. A: ANK2 expression levels in pan-cancer were measured using UALCA database. B: Comparison of ANK2 expression between LUAD and non-paired healthy tissues in TCGA. C: Comparison of ANK2 expression between LUAD and paired healthy tissues in TCGA. D: Comparison of ANK2 expression between healthy lung epithelial cell line (BEAS-2B) and LUAD cell lines (PC9, H1975, A549, and HCC827) (*P < 0.05, ***P < 0.001)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us